BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9353568)

  • 1. Anti-platelet aggregation activity of some pyrazines.
    Ohta A; Takahashi H; Miyata N; Hirono H; Nishio T; Uchino E; Yamada K; Aoyagi Y; Suwabe Y; Fujitake M; Suzuki T; Okamoto K
    Biol Pharm Bull; 1997 Oct; 20(10):1076-81. PubMed ID: 9353568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitory effect of TBN on platelet aggregation in rabbit].
    Xu CL; Shan LC; Sun YW; Wang YQ
    Zhong Yao Cai; 2010 Sep; 33(9):1450-3. PubMed ID: 21243778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on as-triazine derivatives. XIX. Synthesis of 2,3-diarylpyrazine 2,3-diarylpyridine derivatives as blood platelet aggregation inhibitors].
    Konno S; Matsuya Y; Kumazawa M; Amano M; Kokubo T; Sagi M; Yamanaka H
    Yakugaku Zasshi; 1993 Jan; 113(1):40-52. PubMed ID: 8463956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anti-platelet activity of obovatol derivatives.
    Kwak JH; Lee S; Park ES; In JK; Song J; Kim YJ; Choi NS; Lee H; Yun YP; Hong JT; Kwak YS; Min KH; Jung JK
    Arch Pharm Res; 2011 Jul; 34(7):1107-12. PubMed ID: 21811917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
    Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
    Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazole derivatives as inhibitors of arachidonic acid-induced platelet aggregation.
    Levent S; Çalışkan B; Çiftçi M; Özkan Y; Yenicesu I; Ünver H; Banoglu E
    Eur J Med Chem; 2013 Jun; 64():42-53. PubMed ID: 23639653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Design, synthesis and anti-platelet aggregation activities of ligustrazine-tetrahydroisoquinoline derivatives].
    Xie D; Zhang EL; Li JM; Wang J; He GW
    Yao Xue Xue Bao; 2015 Mar; 50(3):326-31. PubMed ID: 26118112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New pyrazolylhydrazone derivatives as inhibitors of platelet aggregation.
    da Silveira IA; Paulo LG; de Miranda AL; Rocha SO; Freitas AC; Barreiro EJ
    J Pharm Pharmacol; 1993 Jul; 45(7):646-9. PubMed ID: 8105062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet activity of some prenylflavonoids.
    Lin CN; Shieh WL; Ko FN; Teng CM
    Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists.
    Asaki T; Hamamoto T; Sugiyama Y; Kuwano K; Kuwabara K; Niwa T
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6588-92. PubMed ID: 17920266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
    Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-platelet aggregation activity of stilbene derivatives from Rheum undulatum.
    Ko SK; Lee SM; Whang WK
    Arch Pharm Res; 1999 Aug; 22(4):401-3. PubMed ID: 10489881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of catechol derivatives on arachidonic acid-induced aggregation of rabbit platelets.
    Kitagawa S; Fujisawa H; Baba S; Kametani F
    Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):1062-4. PubMed ID: 1909935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligustrazine, allicin and shear-induced platelet aggregation.
    Liao F; Jiao L
    Clin Hemorheol Microcirc; 2000; 22(2):167-8. PubMed ID: 10831067
    [No Abstract]   [Full Text] [Related]  

  • 16. New platelet aggregation inhibitors based on pyridazinone moiety.
    Costas T; Costas-Lago MC; Vila N; Besada P; Cano E; Terán C
    Eur J Med Chem; 2015 Apr; 94():113-22. PubMed ID: 25757094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro study of the effects of various 4-hydroxyisophthalic acid derivatives on human platelet aggregation].
    De Cunto M; Berrettini M; Parise P; De Regis M; Orzalesi G; Nenci GG
    Boll Soc Ital Biol Sper; 1983 Mar; 59(3):302-8. PubMed ID: 9704126
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the effects of several zoanthamine-type alkaloids on the aggregation of human platelets.
    Villar RM; Gil-Longo J; Daranas AH; Souto ML; Fernández JJ; Peixinho S; Barral MA; Santafé G; Rodríguez J; Jiménez C
    Bioorg Med Chem; 2003 May; 11(10):2301-6. PubMed ID: 12713841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of new 1,3,4-thiadiazines on platelet aggregation in vitro and ex vivo].
    Logvinova OS; Vasil'eva TM; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
    Eksp Klin Farmakol; 2010 Aug; 73(8):21-5. PubMed ID: 20919553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of sulfur-containing compounds in Scorodocarpus borneensis Becc. on the aggregation of rabbit platelets.
    Lim H; Kubota K; Kobayashi A; Seki T; Ariga T
    Biosci Biotechnol Biochem; 1999 Feb; 63(2):298-301. PubMed ID: 10192909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.